Question: Teva Pharmaceutical Industries Ltd. (TEVA) and Procter & Gamble Co. (PG) agreed to combine their consumer-health businesses outside North America in a joint venture that

Teva Pharmaceutical Industries Ltd. (TEVA) and Procter & Gamble Co. (PG) agreed to combine their consumer-health businesses outside North America in a joint venture that aims to capture more of the $200 billion market for over-the-counter medicines.

The copy of the press release is found by Googling Procter and Gamble and Teva joint venture. I believe the following address will work http://news.pg.com/press-release/pg-corporate-announcements/procter-gamble-company-and-teva-pharmaceutical-industries-a (Links to an external site.)Links to an external site. (but do not guarantee this since the internet changes).

After reviewing this article, do you think this is a wealth increasing project for P&G? why or why not? And what competitive advantages does P&G bring to this joint venture? What capital projects/ investment will be needed?

Step by Step Solution

3.44 Rating (151 Votes )

There are 3 Steps involved in it

1 Expert Approved Answer
Step: 1 Unlock

Teva and the Procter Gamble Company Have Agreed to Terminate the PGT Healthcare Partnership APRIL 19 2018 CORPORATE BUSINESSDEVELOPMENT Teva Pharmaceutical Industries NYSE and TASE TEVA has announced ... View full answer

blur-text-image
Question Has Been Solved by an Expert!

Get step-by-step solutions from verified subject matter experts

Step: 2 Unlock
Step: 3 Unlock

Students Have Also Explored These Related Accounting Questions!